Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer: A Belgian expert opinion
I. Vergote, H. Denys, S. Altintas, J. Kerger, J-F. Baurain, V. Bours, S. Henry, K. Van de Vijver, D. Lambrechts, C. Gennigens
Abstract | PDF
